In this episode of Make Medicines Affordable, Melissa Barber, Global Health Advocacy and Policy Advisor at MSF USA, Carlotta Baptista da Silva, Programme and Advocacy Lead on HIV Access at MSF, and Marcela Vieira Regional Advisor for the Americas Hub at MSF Access, discuss Gilead’s voluntary license for lenacapavir and its implications for global access to HIV prevention. The episode explores pricing, supply constraints, and why the license may limit access in many countries.